000			01922 a2200565 4500
005			20250517190452.0
264		0	_c20190708
008			201907s 0 0 eng d
022			_a2045-2322
024	7		_a10.1038/s41598-017-16928-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aHutzler, Stefan
245	0	0	_aAntigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles. _h[electronic resource]
260			_bScientific reports _c12 2017
300			_a16892 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntigen Presentation
650	0	4	_aAntigens, Neoplasm _xgenetics
650	0	4	_aAutoantibodies _xblood
650	0	4	_aCancer Vaccines _xgenetics
650	0	4	_aCell Line, Tumor
650	0	4	_aChlorocebus aethiops
650	0	4	_aClaudins _xgenetics
650	0	4	_aImmunity, Cellular
650	0	4	_aImmunity, Humoral
650	0	4	_aInterferon-gamma _xmetabolism
650	0	4	_aLung Neoplasms _xsecondary
650	0	4	_aMeasles virus _xgenetics
650	0	4	_aMelanoma, Experimental _ximmunology
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aOncolytic Virotherapy
650	0	4	_aOvalbumin _xgenetics
650	0	4	_aVaccines, Virus-Like Particle _xgenetics
650	0	4	_aVero Cells
700	1		_aErbar, Stephanie
700	1		_aJabulowsky, Robert A
700	1		_aHanauer, Jan R H
700	1		_aSchnotz, Jürgen H
700	1		_aBeissert, Tim
700	1		_aBodmer, Bianca S
700	1		_aEberle, Regina
700	1		_aBoller, Klaus
700	1		_aKlamp, Thorsten
700	1		_aSahin, Ugur
700	1		_aMühlebach, Michael D
773	0		_tScientific reports _gvol. 7 _gno. 1 _gp. 16892
856	4	0	_uhttps://doi.org/10.1038/s41598-017-16928-8 _zAvailable from publisher's website
999			_c27852975 _d27852975